D. E. Shaw & Co., Inc. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$58,434
-44.4%
19,478
-54.4%
0.00%
Q2 2023$105,084
+5.8%
42,717
-2.8%
0.00%
Q1 2023$99,354
+81.7%
43,962
+180.5%
0.00%
Q4 2022$54,695
-98.1%
15,672
-80.0%
0.00%
-100.0%
Q3 2022$2,895,000
+923.0%
78,206
+645.7%
0.00%
Q1 2022$283,00010,4870.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders